MedKoo Cat#: 207152 | Name: LY-3475070
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer.

Chemical Structure

LY-3475070
LY-3475070
CAS#2375815-63-5

Theoretical Analysis

MedKoo Cat#: 207152

Name: LY-3475070

CAS#: 2375815-63-5

Chemical Formula: C15H18N4O2

Exact Mass: 286.1430

Molecular Weight: 286.34

Elemental Analysis: C, 62.92; H, 6.34; N, 19.57; O, 11.18

Price and Availability

Size Price Availability Quantity
100mg USD 2,950.00 2 Weeks
200mg USD 4,250.00 2 Weeks
500mg USD 6,950.00 2 Weeks
1g USD 8,950.00 2 Weeks
2g USD 14,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
LY-3475070; LY 3475070; LY3475070; CD73-IN-3
IUPAC/Chemical Name
5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione
InChi Key
WHRUIISQCORGKK-KOLCDFICSA-N
InChi Code
InChI=1S/C15H18N4O2/c1-7(2)9-4-11(9)10-5-13(19-18-8(10)3)12-6-16-15(21)17-14(12)20/h5-7,9,11H,4H2,1-3H3,(H2,16,17,20,21)/t9-,11+/m1/s1
SMILES Code
O=C1NC(C(C2=NN=C(C)C([C@@H]3[C@@H](C(C)C)C3)=C2)=CN1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay).
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 78.5 274.15
Ethanol 10.0 34.92
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 286.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
[1]. Robert Dean Dally, et al. Cd73 inhibitors. Patent WO2019168744 A1. https://patents.google.com/patent/WO2019168744A1/en?oq=WO2019168744+